Incretin-based therapy and risk of pancreatic cancer in patients with Type 2 Diabetes Mellitus: A meta-analysis of randomized controlled trials

被引：0
|
作者：
Chen, Han [1 ]
Zhou, Xiaoying [1 ]
Zhang, Guoxin [1 ]
机构：
[1] Nanjing Med Univ, Affliated Hosp 1, Dept Gastroenterol, Nanjing, Jiangsu, Peoples R China
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2016年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
519
引用
收藏
页码：256 / 257
页数：2
相关论文
共 50 条
  • [1] Incretin-Based Therapy and Risk of Pancreatic Cancer in Patients with Type 2 Diabetes Mellitus: A Meta-analysis of Randomized Controlled Trials
    Han Chen
    Xiaoying Zhou
    Tao Chen
    Bingtuan Liu
    Wujuan Jin
    Huiyuan Gu
    Tianyuan Hong
    Guoxin Zhang
    [J]. Diabetes Therapy, 2016, 7 : 725 - 742
  • [2] Incretin-Based Therapy and Risk of Pancreatic Cancer in Patients with Type 2 Diabetes Mellitus: A Meta-analysis of Randomized Controlled Trials
    Chen, Han
    Zhou, Xiaoying
    Chen, Tao
    Liu, Bingtuan
    Jin, Wujuan
    Gu, Huiyuan
    Hong, Tianyuan
    Zhang, Guoxin
    [J]. DIABETES THERAPY, 2016, 7 (04) : 725 - 742
  • [3] Incretin-Based Therapy and Risk of Pancreatic Cancer in Patients with Type 2 Diabetes Mellitus: A Meta-Analysis of Randomized Controlled Trials.
    Chen, Han
    Zhou, Xiaoying
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S9 - S10
  • [4] Incretin-based therapies and risk of pancreatic cancer in patients with type 2 diabetes: A meta-analysis of randomized controlled trials
    Wang, Haining
    Liu, Ye
    Tian, Qing
    Yang, Jin
    Lu, Ran
    Zhan, Siyan
    Haukka, Jari
    Hong, Tianpei
    [J]. DIABETES OBESITY & METABOLISM, 2018, 20 (04): : 910 - 920
  • [5] Cardiovascular safety of incretin-based therapy for type 2 diabetes: A meta-analysis of randomized trials
    Mahmoud, Ahmed N.
    Saad, Marwan
    Mansoor, Hend
    Elgendy, Akram Y.
    Barakat, Amr F.
    Abuzaid, Ahmed
    Mentias, Amgad
    Elgendy, Islam Y.
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 230 : 324 - 326
  • [6] Cardiovascular Effect of Incretin-Based Therapy in Patients with Type 2 Diabetes Mellitus: Systematic Review and Meta-Analysis
    Kim, Je-Yon
    Yang, Seungwon
    Lee, Jangik I.
    Chang, Min Jung
    [J]. PLOS ONE, 2016, 11 (04):
  • [7] Incretin-Based Treatments and the Risk of Pancreatic Cancer in Patients with Type 2 Diabetes
    Avenin, Guillaume
    Bertrand, Marion
    Druet, Celine
    Yoldjan, Isabelle
    Zureick, Mahmoud
    Dray-Spira, Rosemary
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 541 - 541
  • [8] Update on Cardiovascular Safety of Incretin-Based Therapy in Adults With Type 2 Diabetes Mellitus: A Meta-Analysis of Cardiovascular Outcome Trials
    Alfayez, Osamah M.
    Almutairi, Abdulaali R.
    Aldosari, Ali
    Al Yami, Majed S.
    [J]. CANADIAN JOURNAL OF DIABETES, 2019, 43 (07) : 538 - +
  • [9] Incretin-Based Therapy of Type 2 Diabetes Mellitus
    Knop, Filip K.
    Vilsboll, Tina
    Holst, Jens J.
    [J]. CURRENT PROTEIN & PEPTIDE SCIENCE, 2009, 10 (01) : 46 - 55
  • [10] Incretin-Based Therapy for Type 2 Diabetes Mellitus: Pancreatic and Extrapancreatic Effects
    Hartman, Israel
    Rojas, Edward
    Rodriguez-Molina, Daloha
    [J]. AMERICAN JOURNAL OF THERAPEUTICS, 2013, 20 (04) : 384 - 393
12345